| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 33,049 | 27,151 | 28,525 | 26,645 | | Cost of Revenue | 6,670 | 5,756 | 5,919 | 5,090 | | | Gross Profit | 26,379 | 21,395 | 22,606 | 21,555 | | | Operating Expenses | | Research Development | 2,008 | 1,407 | 1,602 | 1,611 | | Selling General and Administrative | 23,338 | 22,570 | 16,139 | 16,363 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,033 | (2,582) | 4,865 | 3,581 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 247 | 106 | 579 | 150 | | Earnings Before Interest And Taxes | 1,280 | (2,476) | 5,444 | 3,731 | | Interest Expense | 1,754 | 1,718 | 820 | 643 | | Income Before Tax | (474) | (4,194) | 4,624 | 3,088 | | Income Tax Expense | 82 | 141 | (305) | 113 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (556) | (4,335) | 4,929 | 2,975 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (556) | (4,335) | 4,929 | 2,975 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($556) | ($4,335) | $4,929 | $2,975 |
|
1.05% Nasdaq 
Income Statement
